Understanding how a protein affects Hepatitis B virus infection
Role of Human Apolipoprotein E in Hepatitis B Virus Infection andMorphogenesis
This study is looking at how a protein called apoE affects the Hepatitis B virus, with the goal of finding new ways to treat people who have chronic HBV infections, since current treatments don’t completely get rid of the virus.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wake Forest University Health Sciences NIH-funded |
| Lab location | 1 site (Winston-Salem, United States) |
| Project ID | NIH-11059365 on NIH RePORTER |
What this research studies
This research investigates the role of human apolipoprotein E (apoE) in the infection and development of the Hepatitis B virus (HBV). The study aims to uncover how apoE interacts with HBV, which could lead to new antiviral therapies for chronic HBV infection. By examining the mechanisms of HBV replication and morphogenesis, researchers hope to identify novel targets for drug development. This research is particularly important as current treatments do not effectively eliminate the virus from infected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are chronically infected with Hepatitis B virus.
Not a fit: Patients who are not infected with Hepatitis B or those who have resolved infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new antiviral treatments that effectively eliminate chronic Hepatitis B infections.
How similar studies have performed: Other research has shown promise in targeting viral mechanisms for treatment, but the specific role of apoE in HBV infection is still being explored.
Where this research is happening
Winston-Salem, United States
- Wake Forest University Health Sciences — Winston-Salem, United States (Active)
Researchers
- Principal investigator: Luo, Guangxiang George — Wake Forest University Health Sciences
- Study coordinator: Luo, Guangxiang George
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.